I TRODUCTIO
The flavonoids are natural compounds possessing a large range of biochemical and pharmacological properties [1] including antitumoral activities [2] . Among the flavonoids identified as potential anticancer agents, flavone-8-acetic acid (FAA; 2-phenyl-8-(carboxymethyl)benzopyran-4-one; NSC-347512; LM975; Figure 1 -A) emerged as an interesting lead because of its potent anticancer activity in mouse solid tumors [3] [4] [5] [6] and also in human tumors transplanted in nude mice [7;8] . However, despite its impressive antitumor activity reported in murine models, FAA has not shown anticancer activity in humans [9;10] . This marked interspecies difference in FAA anticancer activity has been hypothesized to be due to a possible metabolic activation of this flavonoid in vivo in mice [11;12] .
The mechanism of anticancer activity of FAA in mice is not fully elucidated. FAA is weakly cytotoxic in vitro but is active in vivo when the same cell lines are transplanted in mice [12] [13] [14] . In view of this discrepancy between in vivo and in vitro effectiveness, several indirect mechanisms of anticancer action have therefore been suggested: augmentation of natural killer activity and induction of interferon [15] ; antiangiogenic properties [16] ; tumor blood flow shut down and induction of extensive hemorrhagic necrosis [3;17-20] . At the molecular level, FAA has been reported to induce DNA damage in Glasgow osteogenic sarcoma after in vivo administration, which could hint to an in vivo formation of reactive metabolites in mice [21] .
In view of the poor cytotoxic activity of FAA in vitro and its potent anticancer activity in vivo in mice, the requirement for FAA metabolic activation has therefore been hypothesized [11;12] . In a search for potentially active FAA metabolites, we have previously identified six FAA phase I metabolites formed in vitro using mouse microsomes [22] . The identified metabolites include three monohydroxylated derivatives (3'-OH-FAA, 4'-OH-FAA and 6-OH-FAA), two epoxides (3', , and one dihydrodiol inserm-00709942, version 1 -19 Jun 2012 (3',4'-dihydodiol-FAA) (Figure 1-A) [22] . We have also shown that human microsomes were unable to metabolize this compound to a significant extent, as compared with mouse microsomes [22] . Although the mouse genome contains 72 putatively functional CYP genes compared to only 27 in humans [23] , the cytochrome P450s (CYP) sub-families mostly involved in drug metabolism, i.e., the CYP1A, CYP2B, CYP2E, CYP3A and CYP4A appear to be roughly similar between mouse and man, although differences are observed in activity and also in inhibition studies [24;25] .
Although mouse microsomes were shown to metabolize FAA, the enzymes responsible for their production are not presently identified. The purpose of the present study was therefore to identify the mouse enzymes involved in the formation of the principal FAA metabolites. The identification of the various mouse cytochrome P450s (Cyps, in lower case for mice) was accomplished using Cyp-specific inhibitors, and the implication of epoxide hydrolase was tested using elaidamide, a specific epoxide hydrolase inhibitor. In addition, because flavonoids have been shown to influence the expression of several Cyps after in vivo administration [26] , the influence of FAA treatment in mice on the expression of the principal hepatic Cyps was also investigated using quantitative RT-PCR. We have found that different sets of Cyps are involved in the formation of specific FAA metabolites and that FAA was shown to induce several hepatic Cyps after in vivo administration in mice.
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MATERIALS A D METHODS
Chemicals. LM975, NSC347512, and FAA mono-hydroxylated products at position 3' or 4' were kindly provided by Dr Jean-Jacques Berthelon (Merck-Lipha Santé, Lyon, France). The 6-OH-FAA was synthesized as previously described [22] using appropriate starting material [27] [28] [29] . The 3',4'-dihydrodiol-FAA, the 3',4'-epoxy-FAA and the 5,6-epoxy-FAA were generated in vitro using aroclor 1254 induced mouse microsomes according to the protocol described below. The following Cyp inhibitors were purchased from Sigma-Aldrich: furafylline (Cyp1a2), α-naphthoflavone (Cyp1b1), tranylcypromine (Cyp2c29, Cyp2c39), quercetin (Cyp2c29), quinidine (Cyp2d9), diethyldithiocarbamate (Cyp2e1) and ketoconazole (Cyp3a11). The specific epoxide hydrolase inhibitor elaidamide was synthesized and kindly provided by Dr Christophe Morisseau [30] . Aroclor 1254 was obtained from Sigma-Aldrich (Saint Quentin Fallavier, France). All other chemicals were obtained from commercial suppliers and were of the highest purity available.
Preparation of aroclor-induced mouse microsomes. Aroclor-induced mouse microsomes were prepared according to the protocol described by Breinholt et al. [31] . Female C57Bl/6 mice, 8 weeks of age were purchased from Janvier (Le Genest-St-Isle, France) and acclimated for a week in our animal facility and kept on a 12 h light/dark cycle with free access to food. Mice were injected intraperitoneally with aroclor-1254 (500 mg/kg body weight) dissolved in corn oil on day 0, and 5 days later the mice were sacrificed by cervical dislocation after a 24 h fasting period. All animal experiments complied with the French regulations concerning the protection of animals used for experimental and other scientific purposes (D2001-486), and with the European Commission regulations (OJ of ECL358 12/18/1986) . The hepatic microsomes were prepared as described by Guengerich inserm-00709942, version 1 -19 Jun 2012 [32] . Briefly, the livers were immediately excised and rinsed in ice-cold KCl 1.15 % solution, pooled and cut into small pieces with scissors. Four volumes of 0.1 M phosphate buffer (pH 7.4) were added and the livers homogenized using a Teflon potter at a speed of 50 rpm with 10 strokes. The liver homogenate was centrifuged at 15,000 × g for 20 min. After lipid elimination, the supernatant was ultra-centrifuged at 100,000 × g during 60 min, at 4°C. The pellet containing the microsomes were collected, covered by a phosphate buffer containing 20% glycerol, snap frozen on dry ice, and stored at -80°C until use. Total microsomal protein was determined using the Pierce BCA Protein Assay Reagent Kit (Rockford, IL,USA).
In vitro metabolism of FAA. Metabolism of FAA was carried out according to our previously described protocol [22] . In brief, FAA (8 µg/ml final concentration) was incubated in 300 µl TRIS-HCL 0.1 M buffer, pH 7.4, containing 0.5 mg/ml microsomal protein, 1.6 mg/ml BSA, 5 mM MgCl 2 and a NADPH generating system corresponding to 1.3 mM. The incubation was carried out in opened 2 ml polypropylene tubes in a shaking water bath (150 oscillations/min) at 37°C. The reaction mixture was pre-warmed at 37°C for 3 min before the NADPH generating system was added and the incubation time was extended for an additional 60 min. The generation of metabolites was linear with time up to 2 h and protein concentration up to 2 mg/ml of microsomal protein, therefore the conditions used in the inhibition experiments (1 h and 0.5 mg/ml protein) were within the linear range. The incubation mixture was extracted twice with 800 µl ethyl acetate containing 2% acetic acid (v/v), the organic phase was evaporated under nitrogen and kept in dry form at -80°C, and then reconstituted with 300 µl of the HPLC mobile phase immediately prior HPLC analysis.
One hundred µl of the reconstituted residue were injected onto the Shimadzu HPLC system. In these incubation conditions, mouse aroclor-induced microsomes could metabolize 4.3 ± 0.3 % of the FAA.
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Determination of mouse Cyp enzymes involved in the FAA metabolism in vitro.
To determine mouse Cyps involved in the FAA metabolism, FAA metabolism by aroclorinduced mouse microsomes in vitro was carried out in absence or presence of various concentrations of specific Cyp inhibitors. The mouse Cyp orthologs corresponding to their human CYP counterparts are as follows [23] : Cyp1a2, CYP1A2; Cyp1b1, CYP1B1; Cyp2b9, CYP2B6; Cyp2c39, CYP2C19; Cyp2d9, CYP2D6; Cyp2e1, CYP2E1; Cyp3a11, CYP3A4.
The specific Cyp inhibitors used were: furafylline (Cyp1a2), α-naphthoflavone (Cyp1b1) [33] , tranylcypromine (Cyp2c29), quinidine (Cyp2d9) [34] , diethyldithiocarbamate (Cyp2e) [35] and ketoconazole (Cyp3a11) [36] . Furafylline, α-naphthoflavone and ketoconazole were dissolved in DMSO, quercetin was dissolved in methanol, and tranylcypromine, quinidine, and diethyldithiocarbamate were dissolved in Tris-HCl buffer. Appropriate controls were run for the solvents which did not exceed 2% in volume in the control tube and in the test tube.
The choice of inhibitors range concentrations were based on Bogaards et al. [24] (and references therein). The inhibitors were added to the incubation mixture containing microsomes 10 min before the addition of the NADPH generating system. The incubation and extraction conditions were carried out as described above for aroclor-induced mouse microsomes.
Epoxide hydrolase inhibition. Because the 3',4'-dihydrodiol-FAA was likely generated from the hydolysis of the 3',4'-epoxy-FAA by the epoxide hydrolase, we determined the role of this enzyme using elaidamide, an epoxide hydrolase inhibitor [30] , at final concentrations of 2, 4 and 10 µM. Evaluation of direct or indirect hydroxylation. In order to determine if FAA monohydroxylates were formed directly from FAA or indirect via epoxidation (Guengerich et al., 2003) , FAA metabolism by aroclor-1254 induced mouse microsomes was carried out in presence of the epoxide scanvenger N-acetyl cysteine (NAC) according to the protocol described by Bu et al. [37] . In brief, NAC was added to the the pre-warmed incubation mixture at a final concentration of 7.5 mM. FAA metabolites and NAC adducts were further analyzed on the LC/MS systems described below. [38] , β-naphthoflavone, 80 mg/kg/day, i.p., suspended in corn oil, for 3 consecutive days [39] ; Dexamethasone, 100 mg/kg/day, i.p., suspended in corn oil, for 3 consecutive days [39] ; for all the previous treatments, the mice were sacrificed on the fifth day after an overnight fasting. Aroclor 1254 (500 mg/kg, dissolved in corn oil) was administered on day 1, and the mice were sacrificed on the 5th day after an overnight fasting [31] . Phenobarbital was administered in drinking water (0.1 %) for 10 days, and the mice were sacrificed on the 11th day after an overnight fasting. For FAA, two treatment schedules were tested: FAA treatment A, consisted of one i.p. one dose on day 1 (180 mg/kg), and the mice were sacrificed on day 5 after an overnight fasting [3;4] FAA treatment B included 3 i.p. administration (at 180 mg/kg each) on days 1, 3 and day 5, and the mice were sacrificed on day 9 after an overnight fasting [3;4] . Immediately upon sacrificing the mice (CO 2 ), the liver was quickly removed, rinsed with ice cold PBS, and aliquots of each liver software using the GenBank reference sequences (Table 1) . They were chosen in such a manner to be in distinct exons, to ensure a specific cDNA versus genomic DNA amplification, and their specificity was assessed using the NCBI BLAST website. Reactions were run in a 5 µl volume in duplicate, with 2 µL of cDNA solution, 2.5 µL of Power SYBR Green Master Mix (Applied Biosystems) and 0.5µL of 10 µM primers solution. The PCR program was: 95°C for 10 min, followed by 45 cycles of (15 seconds at 95°C; 1 min at 60°C).
HPLC-UV and HPLC-UV
Cycle threshold values were obtained from the ABI PRISM 7900 SDS software. For each PCR well, raw fluorescence data were exported and a curve-fitting method was applied to evaluate the individual efficiencies [40] . For each target the efficiency was considered as shared for all wells. This efficiency was set as the mean of the fitted individual efficiencies.
Individual Ct values exported from the SDS software were used to calculate the relative expression level of target t in sample S: Fluorescence was continuously read at 80°C for 30 sec, a condition which ensures exclusive cDNA measurement [41] .
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RESULTS
FAA metabolism using aroclor-induced mouse microsomes. Figure 1 -A presents the structures of FAA metabolites formed by aroclor-induced mouse microsomes, and Figure   1 -B depicts a typical HPLC-UV chromatogram of FAA and its major phase I metabolites. The parent compound FAA eluted at 17.1 min, whereas the six previously identified metabolites [22] , that were all more hydrophilic than FAA, eluted at the following retention times in this reversed-phase HPLC system ( Mouse Cyp enzymes involved in FAA metabolism. In order to identify the mouse Cyps involved in FAA metabolism, incubations were carried out in absence or presence of increasing concentrations of the Cyp-specific inhibitors presented in Table 2 . The possible interference between FAA metabolites and inhibitors (or their possible metabolites) was also assessed by incubating the inhibitors alone with mouse microsomes.
Furafylline, a Cyp1a2 inhibitor, was tested in the concentration range of 5, 10, 20 and 50 µM. In absence of furafylline, all the above identified FAA metabolites were detected ( Fig.   2-A) . In presence of furafylline (Rt, 5.2 min), which did not interfere with the elution profile of FAA metabolites ( Fig. 2-B) , all the FAA metabolites were reduced up to maximal values of 36 to 57% at the maximal inhibitor concentration used (50 µM) ( The Cyp1b1 inhibitor α-naphthoflavone was tested at final concentrations ranging from 5 to 20 µM (Table 2 ). Most FAA metabolites were highly inhibited in presence of α-naphthoflavone and the reduction of metabolite areas was also inhibitor concentrationdependent with values of 70 to 89% at the maximal concentration of inhibitor (20 µM) . Of interest, concerning the 3',4'-epoxy-FAA, a biphasic effect was observed, as the low concentrations of the inhibitor (5 and 10 µM) led to an increase in the production of 3',4'-epoxy-FAA, whereas higher concentrations produced a maximum inhibition of 40% ( Table   2 ). As indicated above, because high concentrations of inhibitor may be involved in unspecific inhibition, it appears that at the intermediate concentration of 10 µM, the following metabolites were inhibited by more than 20%: 3',4'-dihydrodiol-FAA; 5,6-epoxy-FAA; 4'-OH-FAA; and 6-OH-FAA.
The involvement of Cyp2b9 and Cyp2c39 was determined using the inhibitor tranylcypromine. All the metabolites achieved more that 40% inhibition at the the intermediate 50 µM concentration of the inhibitor, with the exception of the 6-OH-FAA (Table 2) .
Quercetin, a Cyp2c29 inhibitor, led to a 52% inhibition of the 3',4'-dihydrodiol-FAA, a 73% inhibition of the 5,6-epoxy-FAA and a 85% inhibition of the 6-OH-FAA at the highest concentration tested of 30 µM (Table 2) production of the 3',4'-dihydrodiol-FAA, probably generated via the 3',4'-epoxy-FAA, is an indirect evidence of an inhibition of these B ring metabolites.
The involvement of Cyp2d9 was determined using quinidine as the inhibitor. Our results demonstrated that Cyp2d9 was not significantly involved in the formation of any metabolite even at a relatively high inhibitor concentration of 10 µM which is twice the usual concentration employed for this inhibitor [24] ( Table 2 ).
In presence of diethyldithiocarbamate, a Cyp2e1 inhibitor, the production of 5,6-epoxy-FAA and 4'-OH-FAA was significantly inhibited (>20%) at an intermediate concentration of this inhibitor (100 µM) ( Table 2 ).
The contribution of Cyp3a11 to the production of FAA metabolites was determined with the specific inhibitor ketoconazole at final concentrations ranging from 2 to 40 µM. In presence of low (2 µM) to moderate (4 µM) concentrations of this inhibitor, only the 3',4',-dihydiol-FAA was highly inhibited by 75% and 88%, respectively, indicating that Cyp3a11 was indeed involved in the formation of the 3',4,-epoxy-FAA intermediate metabolite ( Table   2 ). In presence of the scavenger NAC, all metabolite peaks were reduced (Figure 3-B) .
Determination
However, the 2 epoxides and the 3',4'-dihydrodiol-FAA peaks were more dramatically reduced compared to the other peaks (Figure 3-B) . In parallel to the decrease of two epoxides, we also observed the formation of 4 new peaks at Rt of 26.4, 29.7, 30.2 and 31.5 As mentioned above, it was observed that in presence of NAC, the 4'-OH-FAA, the 3'-OH-FAA and the 6-OH-FAA, were significantly reduced. The 4'-OH-FAA and the 3'-OH-FAA peaks were reduced by 86 and 67%, respectively, whereas the 6-OH-FAA metabolite was diminished by 40% (Figure 3-B) . However, because these peaks were not completely suppressed in presence of the scavenger NAC, this is an indication that direct oxidation of FAA to the monohydroxylated metabolites is also taking place.
inserm-00709942, version 1 -19 Jun 2012
on-enzymatic transformation of the epoxides to their corresponding monohydroxylated FAA derivatives. Because the two FAA epoxides were found unstable and that they apparently were transformed into their corresponding mono-hydroxylated derivatives in the incubation conditions (pH 7.4, 37°C), we next explored the possible contribution of their non-enzymatic transformations to their corresponding phenolic compounds. To do so, FAA metabolite extracts were reconstituted in PBS buffer and incubated at 37°C for 1h. We observed that the peak areas of the 5,6-epoxy-FAA decreased by 47%, whereas the 3',4'-epoxy-FAA decreased by 15%. In parallel, their corresponding phenols, i.e., the 6-OH-FAA peak was doubled (100 % increase), the 4'-OH-FAA was increased by 70%, and the 3'-OH-FAA was increased by 171%. It is of interest that the formation of the 5-OH-FAA was not observed in this experiment. It was also noteworthy that the 3',4'-dihydrodiol-FAA peak area was not altered significantly, indicating that this dihydrodiol is not generated by simple chemical hydrolysis of the corresponding parent epoxide, but could be derived from an enzymatic hydrolysis.
Involvement of microsomal mouse epoxide hydrolase in the formation of 3',4'-dihydrodiol-FAA.
To study the possible involvement of mouse epoxide hydrolase in the formation of the 3',4'-dihydrodiol-FAA, we used elaidamide, a specific epoxide hydrolase inhibitor. In absence of elaidamide, all the FAA metabolites were formed, as presented in Figure 4 -A. The first metabolite peak at Rt of 4.1 min was the 3',4'-dihydrodiol-FAA. In presence of elaidamide (2 to 10 µM), the 3',4'-dihydrodiol-FAA peak was reduced significantly (Figure 4 -B) and the decrease was found to be concentration dependent of the epoxide hydrolase inhibitor as shown in Figure 4 -C.
Effect of FAA treatment on the expression of the principal Cyp enzymes in mice.
Because some flavonoids have been reported to modulate the expression of several enzymes, we next explored the effects of an in vivo treatment of FAA in mice on the expression of the
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principal hepatic Cyps using quantitative RT-PCR. For comparison purposes, the following standard inducers were also included in these experiments: phenobarbital, β-naphthoflavone, 3-methylcholanthrene, dexamethasone and aroclor 1254. The results are presented in Table 3 along with those of FAA after one or three in vivo treatments.
As expected, phenobarbital significantly induced the expression of Cyps 2b10, 2d9
and 3a11, by a factor of 3.2-, 2.5-and 1.6-fold, respectively (Table 3) . Also as expected, β-naphthoflavone, 3-methylcholanthrene and aroclor were all potent inducers of several Cyps of the family 1 (Cyp1a1, 1a2, 1b1) ( Table 3 ). Dexamethasone could also induce the following Cyps: Cyp1a1 (24-fold), 1a2 (4-fold), 1b1 (3.1-fold), 2b10 (1.7-fold), 2d9 (18-fold) and 3a11 (3.6-fold).
Concerning the FAA, one treatment (180 mg/kg i.p.) unexpectedly led to a marked reduction of Cyp 1a1, 1a2 and 1b1 transcripts (Table 3 ). However, after 3 FAA treatments, the following Cyps were significantly induced: Cyp1a2 (1.9-fold), 2e1 (2.1-fold), 2b10 (3.2-fold), 2d9 (2.3-fold), 3a11 (2.2-fold) ( Table 3) .
DISCUSSIO
Although the metabolism of FAA has been hypothesized to be involved in its mechanism of anticancer activity in mice [11;12] , the enzymes involved in FAA metabolism are presently unknown. The purpose of the present work was therefore to identify the principal phase I enzymes involved in FAA metabolism in vitro. In addition, because several flavonoids have been reported to be involved in the modulation of the expression of CYP enzymes [26] , we were also interested to evaluate the possible effect of FAA treatment on the expression of the main Cyps expressed in mouse liver.
The principal FAA metabolites formed in vitro using aroclor-induced mouse microsomes consisted of one dihydrodiol (3',4'-dihydrodiol-FAA), three monohydroxylated metabolites (3'-OH-FAA, 4'-OH-FAA, 6-OH-FAA), and two epoxides (5,6-epoxy-FAA, 3',4'-epoxy-FAA). Of these metabolites, the two epoxides 5,6-epoxy-FAA and 3',4'-epoxy-FAA were the predominant ones representing 36% and 27% of the total metabolites area, respectively.
Using Cyp-specific inhibitors, we have shown that the production of several FAA metabolites could be significantly reduced, thus providing novel information concerning the Cyp families and sub-families that are mostly involved in the formation of these metabolites.
A summary of the principal mouse Cyps involved in FAA metabolism is presented in Figure   5 . It can be noted that for the cycle A oxidation, 5,6-epoxidation was best afforded by Cyps 1a2, 1b1, 2b9, 2c39, 2c29, and 2e1, whereas for the 6-hydroxylation, Cyps 1b1 and 2c29 were the most effective. For cycle B epoxidation (3',4'-epoxy-FAA), Cyp 2b9/2c39 and 3a11 were the principal Cyps involved. For the formation of 4'-OH-FAA, Cyps 1a2, 1b1, 2b9 and 2e1 were the most effective.
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Because monohydroxylation of phenols can also be generated through epoxide intermediates [42;43] , we also evaluated the indirect production of the three monohydroxylated metabolites via an intermediate epoxide using N-acetyl cysteine as an epoxide scavenger. In presence of NAC, the 4'-OH-FAA, the 3'-OH-FAA and the 6-OH-FAA, were significantly reduced, indicating that a significant percentage of these hydroxylated metabolites were indeed derived from the non enzymatic isomerization of their corresponding epoxides. The involvement of epoxide hydrolase in the formation of the 3',4'-dihydrodiol-FAA was also confirmed using elaidamide, a specific inhibitor of this enzyme [30] .
We were next interested to assess the influence of FAA on the expression of the principal hepatic Cyps after an in vivo administration in the mouse, because the expression of these enzymes can indeed be influenced by flavonoids [26] . Using quantitative RT-PCR, FAA was surprisingly found to have a dual effect, i.e., the repression of some Cyps after only one treatment, and the induction of other Cyps after three treatments. Concerning the repression of the expression of Cyps of the 1a subfamily after one in vivo treatment, this rather unexpected result may be due to the fact that some flavonoids may act as ligand of the aryl hydrocarbon receptor (AhR) at low concentrations and repress the transcription of the Cyp1a gene [44] [45] [46] .
For the Cyp1b subfamily no evident mechanism is presently available to explain its repression.
The induction of Cyps 1a2, 2e1, 2b10, 2d9 and 3a11 after three in vivo FAA treatments was also interesting. High concentrations of flavonoids have been previously shown to function as AhR agonists and may therefore activate the transcription of the Cyp1a gene. Since FAA is an unsubstituted flavonoid, it is remarkable that similar unsubstituted flavonoids, e.g., flavone and alpha-naphthoflavone, were also found to induce CYPs 1A1, inserm-00709942, version 1 -19 Jun 2012 1A2 and 2B1/2 [44; 47] . For the other Cyp subfamilies (i.e., 2d, 2e and 3a), there is no published data that we are aware of, concerning the induction of these Cyps by flavonoids.
In conclusion, we have found that several mouse Cyps are involved in the formation of FAA phase I metabolites. The two main metabolites formed in vitro were the 5,6-epoxy-FAA and the 3',4'-epoxy-FAA which were mainly formed by Cyps 1a2, 1b1, 2b9, 2c39, 2c29, and 2e1, for the former, and Cyps 2b9, 2c39, 3a11 for the latter. The formation of 3'-OH-FAA and 4'-OH-FAA were mainly derived from the 3',4'-epoxy-FAA, whereas 6-OH-FAA was mainly formed directly (60%) by Cyps 1b1 and 2c29. After an in vivo administration of FAA in mice, the expression of Cyps 1a1, 1a2 and 1b1 were repressed after one treatment, whereas three treatments led to an induction of Cyps 1a2, 2e1, 2b10, 2d9 and 3a11.
The enzymes identified in FAA metabolism, as well as their in vivo induction could probably play a role in the remarkable anticancer activity of FAA observed in mice. Although only phase I enzymes were studied in the present work, the involvement of other enzymes, particularly phase II enzymes, could also play a role in FAA anticancer activity because some flavonoids have recently been reported to exert their antiproliferative activity through sulfate conjugation [48] . 
